{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T01:18:17Z","timestamp":1785028697714,"version":"3.55.0"},"reference-count":52,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2014,5,22]],"date-time":"2014-05-22T00:00:00Z","timestamp":1400716800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"DOI":"10.1371\/journal.ppat.1004068","type":"journal-article","created":{"date-parts":[[2014,5,22]],"date-time":"2014-05-22T17:00:48Z","timestamp":1400778048000},"page":"e1004068","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":29,"title":["Virus and Autoantigen-Specific CD4+ T Cells Are Key Effectors in a SCID Mouse Model of EBV-Associated Post-Transplant Lymphoproliferative Disorders"],"prefix":"10.1371","volume":"10","author":[{"given":"Stefanie","family":"Linnerbauer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uta","family":"Behrends","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh","family":"Adhikary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Witter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg W.","family":"Bornkamm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Mautner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,5,22]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"7693","DOI":"10.1158\/0008-5472.CAN-08-3301","article-title":"The history of tumor virology","volume":"68","author":"RT Javier","year":"2008","journal-title":"Cancer research"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1128\/CVI.00286-10","article-title":"Translating tumor antigens into cancer vaccines","volume":"18","author":"L Buonaguro","year":"2011","journal-title":"Clinical and vaccine immunology: CVI"},{"key":"ref3","unstructured":"Rickinson AB, Kieff E (2007) Epstein-Barr Virus. In: Knipe DM, Howley, P.M., editor. Fields Virology. 5th ed. Philadelphia: Lippincott Williams &amp; Wilkins. pp. 2575\u20132627."},{"key":"ref4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(95)91150-2","article-title":"Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation","volume":"345","author":"CM Rooney","year":"1995","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s12185-011-0782-2","article-title":"Immunotherapy for EBV-associated malignancies","volume":"93","author":"A Merlo","year":"2011","journal-title":"International journal of hematology"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.coi.2010.12.014","article-title":"Immune defence against EBV and EBV-associated disease","volume":"23","author":"HM Long","year":"2011","journal-title":"Current opinion in immunology"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00262-009-0789-1","article-title":"A novel haplo-identical adoptive CTL therapy as a treatment for EBV-associated lymphoma after stem cell transplantation","volume":"59","author":"M Uhlin","year":"2010","journal-title":"Cancer immunology, immunotherapy: CII"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1182\/blood-2009-08-236356","article-title":"Effective and long-term control of EBV PTLD after transfer of peptide-selected T cells","volume":"115","author":"A Moosmann","year":"2010","journal-title":"Blood"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1182\/blood-2010-03-274076","article-title":"Expansion of EBNA1-specific effector T cells in posttransplantation lymphoproliferative disorders","volume":"116","author":"K Jones","year":"2010","journal-title":"Blood"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1182\/blood-2006-12-063008","article-title":"Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial","volume":"110","author":"T Haque","year":"2007","journal-title":"Blood"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.4049\/jimmunol.0803572","article-title":"Epitope specificity and clonality of EBV-specific CTLs used to treat posttransplant lymphoproliferative disease","volume":"182","author":"KA McAulay","year":"2009","journal-title":"Journal of immunology"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1089\/scd.1.1995.4.73","article-title":"Production of genetically modified Epstein-Barr virus-specific cytotoxic T cells for adoptive transfer to patients at high risk of EBV-associated lymphoproliferative disease","volume":"4","author":"CA Smith","year":"1995","journal-title":"J Hematother"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"3903","DOI":"10.1128\/JVI.02227-07","article-title":"Standardized and highly efficient expansion of Epstein-Barr virus-specific CD4+ T cells by using virus-like particles","volume":"82","author":"D Adhikary","year":"2008","journal-title":"J Virol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1146\/annurev.immunol.25.022106.141553","article-title":"Cellular responses to viral infection in humans: lessons from Epstein-Barr virus","volume":"25","author":"AD Hislop","year":"2007","journal-title":"Annu Rev Immunol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"8649","DOI":"10.1128\/JVI.75.18.8649-8659.2001","article-title":"Differential immunogenicity of Epstein-Barr virus latent-cycle proteins for human CD4(+) T-helper 1 responses","volume":"75","author":"A Leen","year":"2001","journal-title":"Journal of virology"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"4896","DOI":"10.1128\/JVI.79.8.4896-4907.2005","article-title":"CD4+ T-cell responses to Epstein-Barr virus (EBV) latent-cycle antigens and the recognition of EBV-transformed lymphoblastoid cell lines","volume":"79","author":"HM Long","year":"2005","journal-title":"Journal of virology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1084\/jem.191.10.1649","article-title":"Human CD4(+) T lymphocytes consistently respond to the latent Epstein-Barr virus nuclear antigen EBNA1","volume":"191","author":"C Munz","year":"2000","journal-title":"J Exp Med"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"92","DOI":"10.4049\/jimmunol.1100590","article-title":"Cytotoxic CD4+ T cell responses to EBV contrast with CD8 responses in breadth of lytic cycle antigen choice and in lytic cycle recognition","volume":"187","author":"HM Long","year":"2011","journal-title":"Journal of immunology"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1084\/jem.20051287","article-title":"Control of Epstein-Barr virus infection in vitro by T helper cells specific for virion glycoproteins","volume":"203","author":"D Adhikary","year":"2006","journal-title":"J Exp Med"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"e583","DOI":"10.1371\/journal.pone.0000583","article-title":"Immunodominance of Lytic Cycle Antigens in Epstein-Barr Virus-Specific CD4+ T Cell Preparations for Therapy","volume":"2","author":"D Adhikary","year":"2007","journal-title":"PLoS ONE"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1182\/blood-2008-12-194043","article-title":"CD4+ T-cell clones recognizing human lymphoma-associated antigens: generation by in vitro stimulation with autologous Epstein-Barr virus-transformed B cells","volume":"114","author":"HM Long","year":"2009","journal-title":"Blood"},{"key":"ref22","unstructured":"Kieff E, Rickinson AB (2007) Epstein-Barr Virus and Its Replication. In: Knipe DM, Howley, P.M., editor. Field&apos;s virology. 5th ed. Philadelphia: Lippincott Williams &amp; Wilkins. pp. 2603\u20132654."},{"key":"ref23","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/335256a0","article-title":"Transfer of a functional human immune system to mice with severe combined immunodeficiency","volume":"335","author":"DE Mosier","year":"1988","journal-title":"Nature"},{"key":"ref24","first-page":"317","article-title":"EBV-associated B-cell lymphomas following transfer of human peripheral blood lymphocytes to mice with severe combined immune deficiency","volume":"166","author":"DE Mosier","year":"1990","journal-title":"Current topics in microbiology and immunology"},{"key":"ref25","first-page":"218","article-title":"Adoptive transfer of cytotoxic T lymphocytes for the treatment of transplant-associated lymphoma","volume":"114","author":"TJ Boyle","year":"1993","journal-title":"Surgery"},{"key":"ref26","first-page":"735","article-title":"EBV-induced human B cell lymphomas in hu-PBL-SCID mice","volume":"8","author":"DE Mosier","year":"1992","journal-title":"AIDS research and human retroviruses"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1084\/jem.183.3.1215","article-title":"Human Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes home preferentially to and induce selective regressions of autologous EBV-induced B cell lymphoproliferations in xenografted C.B-17 scid\/scid mice","volume":"183","author":"JF Lacerda","year":"1996","journal-title":"The Journal of experimental medicine"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1084\/jem.173.1.147","article-title":"Epstein-Barr virus (EBV)-associated lymphoproliferative disease in the SCID mouse model: implications for the pathogenesis of EBV-positive lymphomas in man","volume":"173","author":"M Rowe","year":"1991","journal-title":"The Journal of experimental medicine"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1136\/jcp.2006.044586","article-title":"Epstein Barr virus-associated tumours: an update for the attention of the working pathologist","volume":"60","author":"HJ Delecluse","year":"2007","journal-title":"J Clin Pathol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1002\/eji.200324794","article-title":"Epstein-Barr virus nuclear antigen 1 evades direct immune recognition by CD4+ T helper cells","volume":"34","author":"J Mautner","year":"2004","journal-title":"Eur J Immunol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1172\/JCI24480","article-title":"Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells","volume":"115","author":"L Gattinoni","year":"2005","journal-title":"The Journal of clinical investigation"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1182\/blood.V92.5.1549","article-title":"Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients","volume":"92","author":"CM Rooney","year":"1998","journal-title":"Blood"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/BF02303813","article-title":"T cells or active Epstein-Barr virus infection in the development of lymphoproliferative disease in human B cell-injected severe combined immunodeficient mice","volume":"1","author":"RE Coles","year":"1994","journal-title":"Annals of surgical oncology"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"13993","DOI":"10.1128\/JVI.79.22.13993-14003.2005","article-title":"Epstein-Barr virus lytic infection contributes to lymphoproliferative disease in a SCID mouse model","volume":"79","author":"GK Hong","year":"2005","journal-title":"Journal of virology"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"13984","DOI":"10.1128\/JVI.79.22.13984-13992.2005","article-title":"Epstein-Barr virus lytic infection is required for efficient production of the angiogenesis factor vascular endothelial growth factor in lymphoblastoid cell lines","volume":"79","author":"GK Hong","year":"2005","journal-title":"Journal of virology"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1002\/cyto.a.20643","article-title":"Phenotype and function of human T lymphocyte subsets: consensus and issues","volume":"73","author":"V Appay","year":"2008","journal-title":"Cytometry Part A: the journal of the International Society for Analytical Cytology"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/44385","article-title":"Two subsets of memory T lymphocytes with distinct homing potentials and effector functions","volume":"401","author":"F Sallusto","year":"1999","journal-title":"Nature"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.trim.2006.10.006","article-title":"Quantitative analysis of EBV-specific CD4\/CD8 T cell numbers, absolute CD4\/CD8 T cell numbers and EBV load in solid organ transplant recipients with PLTD","volume":"17","author":"K Sebelin-Wulf","year":"2007","journal-title":"Transpl Immunol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/00007890-199409150-00020","article-title":"Activity of transplanted CD8+ versus CD4+ cytotoxic T cells against Epstein-Barr virus-immortalized B cell tumors in SCID mice","volume":"58","author":"SD Rencher","year":"1994","journal-title":"Transplantation"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"5895","DOI":"10.4049\/jimmunol.0902850","article-title":"Virus-specific cytotoxic CD4+ T cells for the treatment of EBV-related tumors","volume":"184","author":"A Merlo","year":"2010","journal-title":"Journal of immunology"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1002\/1521-4141(200007)30:7<2065::AID-IMMU2065>3.0.CO;2-W","article-title":"Epstein-Barr virus-dependent lymphoproliferative disease: critical role of IL-6","volume":"30","author":"S Mauray","year":"2000","journal-title":"European journal of immunology"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1200\/JCO.2011.39.8495","article-title":"Adoptive transfer of epstein-barr virus (EBV) nuclear antigen 1-specific t cells as treatment for EBV reactivation and lymphoproliferative disorders after allogeneic stem-cell transplantation","volume":"31","author":"V Icheva","year":"2013","journal-title":"J Clin Oncol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10428190400002202","article-title":"Adoptive immunotherapy for EBV-associated malignancies","volume":"46","author":"S Gottschalk","year":"2005","journal-title":"Leuk Lymphoma"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"4700","DOI":"10.1182\/blood-2010-06-289991","article-title":"Allogeneic virus-specific T cells with HLA alloreactivity do not produce GVHD in human subjects","volume":"116","author":"JJ Melenhorst","year":"2010","journal-title":"Blood"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.cell.2011.12.031","article-title":"Immune surveillance and therapy of lymphomas driven by Epstein-Barr virus protein LMP1 in a mouse model","volume":"148","author":"B Zhang","year":"2012","journal-title":"Cell"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1084\/jem.20040890","article-title":"Cytotoxic T lymphocyte therapy for Epstein-Barr virus+ Hodgkin&apos;s disease","volume":"200","author":"CM Bollard","year":"2004","journal-title":"J Exp Med"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1038\/mt.2009.140","article-title":"Nucleofection of DCs to generate Multivirus-specific T cells for prevention or treatment of viral infections in the immunocompromised host","volume":"17","author":"U Gerdemann","year":"2009","journal-title":"Molecular therapy: the journal of the American Society of Gene Therapy"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1128\/JVI.69.1.231-238.1995","article-title":"Immortalization of human B lymphocytes by a plasmid containing 71 kilobase pairs of Epstein-Barr virus DNA","volume":"69","author":"B Kempkes","year":"1995","journal-title":"J Virol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1093\/emboj\/19.12.3080","article-title":"The Epstein-Barr virus lytic program is controlled by the co-operative functions of two transactivators","volume":"19","author":"R Feederle","year":"2000","journal-title":"EMBO J"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"10357","DOI":"10.1128\/JVI.01193-06","article-title":"Identification of major histocompatibility complex class II-restricted antigens and epitopes of the Epstein-Barr virus by a novel bacterial expression cloning approach","volume":"80","author":"S Milosevic","year":"2006","journal-title":"J Virol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1002\/eji.200323730","article-title":"Major histocompatibility complex class II-restricted presentation of a cytosolic antigen by autophagy","volume":"33","author":"F Nimmerjahn","year":"2003","journal-title":"Eur J Immunol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1007\/s00262-011-1086-3","article-title":"Differential down-modulation of HLA class I and II molecule expression on human tumor cell lines upon in vivo transfer","volume":"60","author":"R Turrini","year":"2011","journal-title":"Cancer immunology, immunotherapy: CII"}],"container-title":["PLoS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.ppat.1004068","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,19]],"date-time":"2020-08-19T16:48:04Z","timestamp":1597855684000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1004068"}},"subtitle":[],"editor":[{"given":"Cliona M.","family":"Rooney","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,5,22]]},"references-count":52,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2014,5,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1004068","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718410851.793496109","asserted-by":"object"}]},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,22]]}}}